Target intelligence / Profile preview

Lymphatic vessels and lymph node macrophages (None)

Target
None
Molecular classification
Other (Cellular/Anatomical System)
01

Overview

Lymphatic vessels and lymph node macrophages constitute a critical anatomical and functional unit of the immune and circulatory systems. Lymphatic vessels are specialized endothelial tubes that maintain tissue fluid balance and transport antigens and immune cells to regional lymph nodes [1]. Within these nodes, specific macrophage subsets, particularly subcapsular sinus macrophages, serve as essential filters that capture pathogens and initiate adaptive immune responses [2]. This system is frequently exploited by metastatic cancer cells for dissemination and is a primary site for vaccine-induced immune activation [3]. Pharmacological intervention often focuses on inhibiting vessel growth (lymphangiogenesis) in malignancy or utilizing the lymphatic route for targeted delivery of immunotherapeutics [4]. Understanding the interplay between lymphatic drainage and macrophage-mediated antigen presentation is vital for developing effective immunotherapies and preventing tumor spread. Key molecular markers for these components include LYVE-1 and VEGFR-3 for vessels, and CD169 for specific macrophage populations [5].

Other names
Lymphatic systemLymphatic microenvironmentLymph node nicheLymphatic-macrophage axis
02

Mechanism of action

Pharmacological agents targeting this system primarily function by inhibiting lymphangiogenesis through the blockade of the VEGFR-3 signaling pathway or by modulating lymphocyte trafficking via sphingosine-1-phosphate (S1P) receptor antagonism.

03

Biological functions

Fluid homeostasisImmune surveillanceAntigen presentationLipid transport
04

Disease associations

Cancer metastasisLymphedemaChronic inflammationAutoimmune disease
05

Safety considerations

LymphedemaImpaired wound healingIncreased risk of infectionReduced vaccine efficacy
06

Interacting drugs

Lenvatinib

3 more in the full profile.

07

Biomarkers

LYVE-1VEGFR-3CD169 (Siglec-1)Podoplanin (PDPN)

Beyond the preview

Go deeper on Lymphatic vessels and lymph node macrophages (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lymphatic vessels and lymph node macrophages (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call